These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 8485812)

  • 1. Role of DNA repair in the mechanisms of cell resistance to alkylating agents and cisplatin.
    Calsou P; Salles B
    Cancer Chemother Pharmacol; 1993; 32(2):85-9. PubMed ID: 8485812
    [No Abstract]   [Full Text] [Related]  

  • 2. Alkylating and platinum-based agents.
    Eastman A
    Curr Opin Oncol; 1990 Dec; 2(6):1109-14. PubMed ID: 2099841
    [No Abstract]   [Full Text] [Related]  

  • 3. Modulation of antitumor alkylating agents (AA).
    Teicher BA; Frei E
    Cancer Treat Res; 1991; 57():261-95. PubMed ID: 1686721
    [No Abstract]   [Full Text] [Related]  

  • 4. Resistance to alkylating agents and cisplatin: insights from ovarian carcinoma model systems.
    Perez RP; Hamilton TC; Ozols RF
    Pharmacol Ther; 1990; 48(1):19-27. PubMed ID: 2274575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alkylating agents, mechanisms of resistance: a review.
    Fox BW
    Prog Clin Biol Res; 1983; 132C():247-55. PubMed ID: 6314356
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanisms of resistance to alkylating agents.
    Colvin OM
    Cancer Treat Res; 1994; 73():249-62. PubMed ID: 7710907
    [No Abstract]   [Full Text] [Related]  

  • 7. Gene expression analysis of tumor spheroids reveals a role for suppressed DNA mismatch repair in multicellular resistance to alkylating agents.
    Francia G; Man S; Teicher B; Grasso L; Kerbel RS
    Mol Cell Biol; 2004 Aug; 24(15):6837-49. PubMed ID: 15254249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. c-MYC suppresses BIN1 to release poly(ADP-ribose) polymerase 1: a mechanism by which cancer cells acquire cisplatin resistance.
    Pyndiah S; Tanida S; Ahmed KM; Cassimere EK; Choe C; Sakamuro D
    Sci Signal; 2011 Mar; 4(166):ra19. PubMed ID: 21447800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. O6-alkylguanine-DNA alkyltransferase. A target for the modulation of drug resistance.
    Gerson SL; Willson JK
    Hematol Oncol Clin North Am; 1995 Apr; 9(2):431-50. PubMed ID: 7642472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of DNA repair and the enhancement of cytotoxicity of alkylating agents.
    Frankfurt OS
    Int J Cancer; 1991 Jul; 48(6):916-23. PubMed ID: 1907257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclosporin A suppresses cisplatin-induced oncogene expression in human cancer cells.
    Scanlon KJ; Wang WZ; Han H
    Cancer Treat Rev; 1990 Dec; 17 Suppl A():27-35. PubMed ID: 2092869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of acquired resistance to cisplatin.
    Andrews PA
    Cancer Treat Res; 1994; 73():217-48. PubMed ID: 7710906
    [No Abstract]   [Full Text] [Related]  

  • 13. Recent progress on the Ada response for inducible repair of DNA alkylation damage.
    Sedgwick B; Lindahl T
    Oncogene; 2002 Dec; 21(58):8886-94. PubMed ID: 12483506
    [No Abstract]   [Full Text] [Related]  

  • 14. Mechanisms of resistance to cisplatin and alkylating agents.
    Hamilton TC; Lai GM; Rothenberg ML; Fojo AT; Young RC; Ozols RF
    Cancer Treat Res; 1989; 48():151-69. PubMed ID: 2577136
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of cisplatin cytotoxicity in human ovarian carcinoma cell lines.
    Shellard S; Hosking L; Fichtinger-Schepman AM; Hill BT
    Biochem Soc Trans; 1990 Aug; 18(4):622. PubMed ID: 2276474
    [No Abstract]   [Full Text] [Related]  

  • 16. XRCC1 and DNA polymerase beta interaction contributes to cellular alkylating-agent resistance and single-strand break repair.
    Wong HK; Wilson DM
    J Cell Biochem; 2005 Jul; 95(4):794-804. PubMed ID: 15838887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA repair in drug resistance: studies on the repair process at the level of the gene.
    Link CJ; Bohr VA
    Cancer Treat Res; 1991; 57():209-32. PubMed ID: 1686718
    [No Abstract]   [Full Text] [Related]  

  • 18. DNA damage and repair in peripheral blood lymphocytes from healthy individuals and cancer patients: a pilot study on the implications in the clinical response to chemotherapy.
    Nadin SB; Vargas-Roig LM; Drago G; Ibarra J; Ciocca DR
    Cancer Lett; 2006 Jul; 239(1):84-97. PubMed ID: 16143448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Xeroderma Pigmentosum Group A Promotes Autophagy to Facilitate Cisplatin Resistance in Melanoma Cells through the Activation of PARP1.
    Ge R; Liu L; Dai W; Zhang W; Yang Y; Wang H; Shi Q; Guo S; Yi X; Wang G; Gao T; Luan Q; Li C
    J Invest Dermatol; 2016 Jun; 136(6):1219-1228. PubMed ID: 26880244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA repair mechanisms and cytotoxicity of antitumour alkylating agents and neutral platinum complexes.
    Roberts JJ
    Antibiot Chemother (1971); 1980; 28():109-14. PubMed ID: 6998359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.